Literature DB >> 24890259

VEGF pathway inhibitors-induced hypertension: next step in therapy.

Peter Kruzliak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24890259      PMCID： PMC8031679          DOI： 10.1111/jch.12348

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  6 in total

Review 1.  Bevacizumab in the treatment of metastatic breast cancer: friend or foe?

Authors:  Alberto J Montero; Mauricio Escobar; Gilberto Lopes; Stefan Glück; Charles Vogel
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Darren R Feldman; Michael S Baum; Michelle S Ginsberg; Hani Hassoun; Carlos D Flombaum; Susanne Velasco; Patricia Fischer; Ellen Ronnen; Nicole Ishill; Sujata Patil; Robert J Motzer
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

Review 3.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 4.  Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors.

Authors:  Peter Kruzliak; Jan Novák; Miroslav Novák
Journal:  Am J Hypertens       Date:  2013-10-29       Impact factor: 2.689

Review 5.  Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis.

Authors:  Yan Li; Shun Li; Yaofeng Zhu; Xinyue Liang; Hui Meng; Jun Chen; Dongqing Zhang; Hu Guo; Benkang Shi
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03       Impact factor: 3.738

Review 6.  Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension.

Authors:  Peter Kruzliak; Gabriela Kovacova; Olga Pechanova
Journal:  Angiogenesis       Date:  2012-12-01       Impact factor: 9.596
  6 in total
  1 in total

1.  Acute hypertension during ramucirumab infusion in two patients with advanced oesophagogastric cancer.

Authors:  Stephanie O van der Woude; Hanneke W M van Laarhoven
Journal:  BMJ Case Rep       Date:  2016-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.